Paper Details
- Home
- Paper Details
Toxicity and antineoplastic effect of (24R)-1,24-dihydroxyvitamin D3 (PRI-2191).
Author: DzimiraStanisław, KutnerAndrzej, KuśnierczykHalina, MadejJanusz, OpolskiAdam, PełczyńskaMarzena, SzelejewskiWiesław, WietrzykJoanna
Original Abstract of the Article :
Many efforts have been made to obtain active and less toxic Vitamin D analogs for new clinical applications. The results of previous studies demonstrated the efficacy and safety of topical treatment of psoriasis with one of these analogs, 1,24-dihydroxyvitamin D(3), tacalcitol (1,24-(OH)(2)D(3)). In...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1016/j.steroids.2004.05.015
データ提供:米国国立医学図書館(NLM)
(24R)-1,24-dihydroxyvitamin D3 (PRI-2191): A New Oasis in the Desert of Cancer Treatment
The search for effective and less toxic cancer treatments is a relentless journey, much like a camel traversing a vast desert in search of a hidden oasis. This research, published in the journal Cancer Letters, explores the potential of (24R)-1,24-dihydroxyvitamin D3 (PRI-2191), an analog of vitamin D3, as a new anti-cancer agent. The researchers investigated the toxicity and antitumor effect of this analog in mouse models of cancer. They found that PRI-2191 exhibited significantly lower lethal toxicity than calcitriol, another vitamin D analog, and also demonstrated a significant antitumor effect in the 16/C mouse mammary cancer model. The study suggests that PRI-2191 may be a promising new anti-cancer agent with a favorable safety profile.
PRI-2191: A New Hope for Cancer Patients
The discovery of the antitumor activity of PRI-2191, a vitamin D analog, is a significant breakthrough in the fight against cancer. It's like finding a hidden oasis in the desert, offering a potential source of relief for cancer patients. The study emphasizes the need for further research to fully understand the potential of this compound and to optimize its use in the clinic.
Navigating the Desert of Cancer Treatment
This research provides valuable insights into the potential of vitamin D analogs as new anti-cancer agents. It's like finding a new and effective weapon in the fight against a formidable enemy. The researchers emphasize the importance of carefully considering the benefits and risks of any new treatment and of conducting further research to ensure its safety and efficacy.
Dr.Camel's Conclusion
The desert of cancer research continues to expand, with researchers constantly seeking new and effective therapies. This study offers a promising lead, highlighting the potential of (24R)-1,24-dihydroxyvitamin D3 (PRI-2191) as a new anti-cancer agent. The study emphasizes the need for further research to fully understand the potential of this compound and to develop safe and effective treatments for cancer patients.
Date :
- Date Completed 2005-03-15
- Date Revised 2013-11-21
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.